Guizhou Yibai Pharmaceutical Co Ltd (600594) — Cash Flow Reinvestment Rate
Guizhou Yibai Pharmaceutical Co Ltd (600594) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥7.08 Million (capex CN¥7.08 Million ) from operating cash flow of CN¥33.28 Million. Explore Guizhou Yibai Pharmaceutical Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guizhou Yibai Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Guizhou Yibai Pharmaceutical Co Ltd across 23 annual periods. Also explore total assets of Guizhou Yibai Pharmaceutical Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)
Year-by-year capital reinvestment analysis for Guizhou Yibai Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Guizhou Yibai Pharmaceutical Co Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.14x | CN¥35.08 Million | CN¥256.71 Million | CN¥34.99 Million | ▼ -89.8% |
| 2024 | 1.34x | CN¥116.31 Million | CN¥86.87 Million | CN¥96.32 Million | ▲ +286.6% |
| 2023 | 0.35x | CN¥130.78 Million | CN¥377.61 Million | CN¥130.38 Million | ▼ -65.1% |
| 2022 | 0.99x | CN¥342.92 Million | CN¥345.30 Million | CN¥322.92 Million | ▲ +69.2% |
| 2021 | 0.59x | CN¥548.48 Million | CN¥934.21 Million | CN¥447.78 Million | ▼ -56.5% |
| 2020 | 1.35x | CN¥494.68 Million | CN¥366.66 Million | CN¥395.74 Million | ▲ +142.1% |
| 2019 | 0.56x | CN¥202.17 Million | CN¥362.71 Million | CN¥201.28 Million | ▼ -62.9% |
| 2018 | 1.50x | CN¥322.01 Million | CN¥214.30 Million | CN¥321.33 Million | ▲ +124.1% |
| 2017 | 0.67x | CN¥457.21 Million | CN¥681.78 Million | CN¥402.80 Million | ▼ -31.6% |
| 2016 | 0.98x | CN¥373.22 Million | CN¥380.62 Million | CN¥332.53 Million | ▲ +95.3% |
| 2015 | 0.50x | CN¥288.02 Million | CN¥573.68 Million | CN¥288.02 Million | ▲ +33.3% |
| 2014 | 0.38x | CN¥203.94 Million | CN¥541.58 Million | CN¥203.94 Million | ▼ -20.5% |
| 2013 | 0.47x | CN¥273.48 Million | CN¥577.24 Million | CN¥273.48 Million | ▼ -34.9% |
| 2012 | 0.73x | CN¥209.64 Million | CN¥288.01 Million | CN¥209.64 Million | ▲ +42.1% |
| 2011 | 0.51x | CN¥142.34 Million | CN¥277.83 Million | CN¥142.34 Million | ▲ +19.3% |
| 2010 | 0.43x | CN¥49.66 Million | CN¥115.66 Million | CN¥49.66 Million | ▼ -0.1% |
| 2009 | 0.43x | CN¥44.62 Million | CN¥103.88 Million | CN¥44.62 Million | ▲ +29.3% |
| 2008 | 0.33x | CN¥62.86 Million | CN¥189.26 Million | CN¥62.86 Million | ▼ -89.8% |
| 2007 | 3.26x | CN¥38.97 Million | CN¥11.94 Million | CN¥38.97 Million | ▲ +1738.0% |
| 2006 | 0.18x | CN¥17.00 Million | CN¥95.77 Million | CN¥17.00 Million | ▼ -96.2% |
| 2005 | 4.66x | CN¥80.99 Million | CN¥17.38 Million | CN¥80.99 Million | ▲ +153.2% |
| 2003 | 1.84x | CN¥169.47 Million | CN¥92.10 Million | CN¥169.47 Million | ▲ +501.0% |
| 2002 | 0.31x | CN¥22.49 Million | CN¥73.46 Million | CN¥22.49 Million | — |